Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

Abroad (travel likely)RecruitingPHASE3

Conditions

Peritoneal Dialysis · Anaemia · Iron Deficiency, Anaemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hull University Teaching Hospitals NHS Trust, Hull, East Riding Of Yorkshire, United Kingdom
Contact: Study coordinator (Sebastian Spencer) · sebastian.spencer2@nhs.net · +44 01482 675093

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis

Hyperphosphatemia Patients on Peritoneal Dialysis

Abroad (travel likely)RecruitingPHASE3

Tokyo, Japan

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

Peritoneal Dialysis Complication · End Stage Kidney Disease · Sodium-glucose Co-transporter-2 Inhibitors

Abroad (travel likely)RecruitingPHASE3

Toronto, Canada

Alirocumab in Patients on a Stable Dialysis Regimen

Hemodialysis · Peritoneal Dialysis · Hypercholesterolemia

Abroad (travel likely)RecruitingPHASE3

Dallas, United States

Probiotic and Prebiotic Supplementation in Peritoneal Dialysis Patients

Chronic Kidney Disease (Stages 4 and 5) · Peritoneal Dialysis (PD)

Abroad (travel likely)Recruiting

Monterrey, Mexico